Cramer’s lightning round: I’m very concerned about Veru

Cramer’s lightning round: I’m very concerned about Veru


Veru Inc: “I’m very concerned about it.”

HealthEquity Inc: “Expensive stock, another one of these stocks not making much money. I think we’re going to have to take a major league pass.”

Bumble Inc: “We’re not seeing the kind of profitability that makes me feel like that stock’s inexpensive.”

Axon Enterprise Inc: “It’s a terrific law enforcement package that I think is really good for everybody. I like it.”

Nuscale Power Corp: “If you want small, nuclear modular reactors, I’m going to have to say, the Constellation Energy group. That’s who’s got it.”

Disclaimer: Cramer’s Charitable Trust owns shares of Coterra.

Cramer's lightning round: I'm very concerned about Veru

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Ticketmaster parent Live Nation reaches settlement with Department of Justice over antitrust concerns
Business

Ticketmaster parent Live Nation reaches settlement with Department of Justice over antitrust concerns

Signs are seen at the Live Nation NYC headquarters on May 23, 2024 in New York City.  Michael M. Santiago | Getty Images Live Nation Entertainment has reached a settlement with the Department of Justice over antitrust concerns surrounding its Ticketmaster platform, a senior DOJ official said Monday. The settlement would see Ticketmaster unwind some […]

Read More
Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More